Drug-induced hyperinsulinemic hypoglycemia: An update on pathophysiology and treatment

Rev Endocr Metab Disord. 2023 Dec;24(6):1031-1044. doi: 10.1007/s11154-023-09828-y. Epub 2023 Aug 8.

Abstract

The initial step for the differential diagnosis of hypoglycemia is to determine whether it is hyperinsulinemic or non hyperinsulinemic. Existing literature discusses drug-related hypoglycemia, but it misses a focus on drug-induced hyperinsulinemic hypoglycemia (DHH). Here we reviewed the association existing between drugs and hyperinsulinemic hypoglycemia. We primarily selected on the main electronic databases (MEDLINE, EMBASE, Web of Science, and SCOPUS) the reviews on drug-induced hypoglycemia. Among the drugs listed in the reviews, we selected the ones linked to an increase in insulin secretion. For the drugs missing a clear association with insulin secretion, we investigated the putative mechanism underlying hypoglycemia referring to the original papers. Our review provides a list of the most common agents associated with hyperinsulinemic hypoglycemia (HH), in order to facilitate both the recognition and the prevention of DHH. We also collected data about the responsiveness of DHH to diazoxide or octreotide.

Keywords: Drug-induced hyperinsulinism; Hyperinsulinism; Hypoglycemia; Review.

Publication types

  • Review

MeSH terms

  • Diazoxide / adverse effects
  • Humans
  • Hyperinsulinism* / chemically induced
  • Hyperinsulinism* / complications
  • Hyperinsulinism* / diagnosis
  • Hypoglycemia* / chemically induced
  • Hypoglycemia* / complications
  • Hypoglycemia* / drug therapy
  • Insulin Secretion

Substances

  • Diazoxide